CAUTION–Investigational Device. Limited by Federal (or United States) Law to Investigational Use.
Corvia Medical’s dedicated team of professionals shares a passion and commitment to advance innovation within the field of structural heart disease, and more specifically, heart failure. Each member of our management team brings extensive experience within the medical device field and a track record of success.
President and Chief Executive Officer
George has been Chief Executive Officer and President at Corvia Medical since 2010. Prior to Corvia Medical, George held numerous leadership positions at St. Jude Medical from October 1992 through December 2009.
His roles at St. Jude Medical included: President of the U.S. Division, President of the Cardiovascular Division, President of the Cardiac Surgery Division, and President of Europe, Middle East, Africa (EMEA) residing in Belgium. George also served as President of Health Care Services where he built the National Accounts function for managing cross-divisional contracting and General Manager of Canadian Operations where he brought St. Jude Medical’s operations direct from a distributor-based distribution model while residing in Toronto, Canada. Prior to St. Jude Medical, George held several positions of increasing responsibility at the Davis & Geck Division of American Home Products from 1984 to 1992 including Marketing-Product Manager, Regional Sales Manager, Sales Training Manager and Sales Representative. George is currently serving on the Board of Directors for BioVentrix Inc. He holds a B.S. from the State University of New York at Albany and an MBA from the Fordham University Graduate School of Business.
Senior Vice President and Chief Medical Officer
Jan brings more than 20 years of medical device experience to Corvia Medical. Prior to joining Corvia Medical, Jan was Executive Vice President and Chief Medical Officer at Guided Delivery Systems, responsible for Clinical, Regulatory, and Quality Assurance.
Prior to Guided Delivery Systems, Jan was Director of Valve Therapy for Abbott Vascular’s structural heart business unit. His career includes executive positions at Evalve, where he was VP of Marketing and Business Development, and subsequently Valve Therapy. In this role, Jan was responsible for technology and procedure development, IDE study enrollment, training and reimbursement, and initial commercial launch. Jan is a veterinary surgeon by training with over 10 years of academic and practice experience. He holds a DVM degree from The University of Utrecht, The Netherlands.
Vice President, R&D and Operations
Ed brings more than 25 years of experience in medical device development with a focus on emerging technologies in the cardiovascular space. His experience includes early prototype development through commercialization, including clinical strategy, regulatory approvals, and patent portfolio development.
Ed came to Corvia Medical from Mitralign, a percutaneous mitral valve repair company where he was Vice President of Engineering. Prior to Mitralign, Ed was the Director of Biomedical Engineering for Lightlab Imaging and was instrumental in its successful sale to Goodman. Ed also held several engineering management positions at two divisions of C.R. Bard, Inc., Bard Interventional Products and the USCI (Cardiology) division. Previously, Ed founded Custom Medical Design Concepts, an OEM research, development and design house. Ed holds a B.S. in Mechanical Engineering from the University of Massachusetts/Lowell.
Vice President, Quality Assurance and Regulatory Affairs
Kate Stohlman brings to Corvia Medical more than 15 years of experience successfully developing and executing regulatory, clinical and quality control strategies for new interventional cardiology devices. Most recently Kate co-founded and held the position of Vice President Regulatory and Clinical Affairs for MitraSpan, a minimally invasive mitral valve repair technology.
Prior to MitraSpan, Kate was the COO for Thermedical, developing a ventricular tachycardia treatment, and VP Clinical and Regulatory Affairs for Viacor, treating mitral regurgitation percutaneously. Previously Kate held factory and global management positions with Hewlett-Packard Company Medical Products and Agilent Technologies with functional responsibilities in manufacturing, product development, and engineering, and a clinical focus on cardiac ultrasound imaging. Kate holds a BS Materials Science from Massachusetts Institute of Technology and MBA from Harvard Business School.